At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy). Goff DC. J Clin Psychopharmacol 2025 Feb 6. doi: 10.1097/JCP.0000000000001959.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goff DC. At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy). J Clin Psychopharmacol 2025 Feb 6. doi: 10.1097/JCP.0000000000001959.
PMID: 39913270